Drugs and biologicals
Ended Awarded Last action
- Contract number
- HHSN26300370
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,238
Award facts
- Contract value 32% obligated
-
- $5,238.42 Current, with exercised options
- $16,605.18 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$445 | |
| Original award | $5,683 |
About this award
On August 13, 2013, the Office of the Director (civilian federal agency) awarded a Blanket Purchase Agreement call to Lonza Walkersville, Inc. for drugs and biologicals with a ceiling value of $16,605.18 under firm fixed pricing. The contract, which was not designated as a set-aside, was performed at the contractor's facility in Walkersville, Maryland, and was scheduled for completion by December 31, 2013. This call order was issued against Lonza Walkersville's larger $10 million single-award BPA with the Health and Human Services (HHS) Office of Logistics and Acquisition Operations, which remained valid through December 2025 and enabled streamlined procurement across multiple NIH institutes and research centers.
Lonza Walkersville, Inc., a foreign-owned subsidiary of the global Lonza Group and registered federal contractor since 2002, specializes in providing high-precision biological research products and scientific services to federal agencies. The company maintains a strong track record supplying the National Institutes of Health, Food and Drug Administration, and the Department of Veterans Affairs with specialized materials including cell culture media, cell lines, and advanced scientific instrumentation. The underlying BPA facilitated efficient acquisition of biological materials, blood products, laboratory supplies, and associated repair and maintenance services supporting critical research across oncology, infectious disease, regenerative medicine, and cellular engineering disciplines.
Quick answers
Who was awarded contract HHSN26300370?
HHSN26300370 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on August 13, 2013.
How much is contract HHSN26300370 worth?
The government has obligated $5,238 on HHSN26300370. Its potential value, with all options, is $16,605.
Is contract HHSN26300370 an order under another contract?
Yes. HHSN26300370 is a BPA call under HHSN263199900049886B, a blanket purchase agreement.
Was contract HHSN26300370 competed?
The extent of competition for HHSN26300370 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award